948895-19-0 Usage
Uses
Used in Medicinal Chemistry:
2,6-DICHLORO-N-(2-(4-OXOPIPERIDIN-1-YL)ETHYL)BENZAMIDE is used as a chemical entity in medicinal chemistry for its potential to contribute to the development of new pharmaceuticals. Its structural components may allow for interactions with biological targets, offering a basis for the design of drugs with specific therapeutic effects.
Used in Drug Development:
In the pharmaceutical industry, 2,6-DICHLORO-N-(2-(4-OXOPIPERIDIN-1-YL)ETHYL)BENZAMIDE is utilized as a compound in drug development. Its unique structure may provide a foundation for the creation of novel therapeutic agents, particularly those targeting specific biological pathways or receptors, thereby addressing unmet medical needs.
Check Digit Verification of cas no
The CAS Registry Mumber 948895-19-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,8,8,9 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 948895-19:
(8*9)+(7*4)+(6*8)+(5*8)+(4*9)+(3*5)+(2*1)+(1*9)=250
250 % 10 = 0
So 948895-19-0 is a valid CAS Registry Number.
948895-19-0Relevant academic research and scientific papers
EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS
-
Page/Page column 18, (2009/06/27)
The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENTl inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENTl receptors in animals, in particular humans.
PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS
-
, (2008/06/13)
The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.
